期刊文献+

绝经后阴道出血210例临床分析 被引量:3

Postmenopausal bleeding:a clinical analysis of 210 cases
原文传递
导出
摘要 目的探讨绝经后阴道出血(postmenopausal bleeding,PMB)的病因、诊断方法及防治。方法回顾性分析210例PMB患者的临床和病理资料。结果引起PMB原因:良性疾病占69.5%,其中感染性疾病49.5%,非器质性病20.5%,恶性肿瘤占10.0%。恶性肿瘤发病年龄(67.1±6.9)岁、绝经年限(11.6±2.9)年、出血持续时间(157.6±26.4)d、子宫内膜厚度(14.6±3.2)mm,与良性疾病及非器质性病差异有统计学意义(P<0.05),而孕次、产次间差异无统计学意义(P>0.05)。结论绝经后阴道出血的主要原因是良性疾病,其次是非器质性疾病。对发病年龄大、绝经时间及出血持续时间长、子宫内膜厚度明显增厚的PMB患者应警惕其恶性肿瘤的发生。 Objective To investigate the causes, diagnostic methods, prevention and cure of postmenopausal bleeding(PMB). Methods The clinical and pathological data of 210 PMB patients admitted in this hospital were retrospectively analyzed. Results The causes for PMB were benign diseases(69.5 % ), the most of which were infectious diseases( 49.5 % ), non-organic disease(20.5 % ) and malignant tumor( 10.0 % )- Compared with benign diseases and non-organic diseases,the attack age of malignant tumor was higher[ (67.1 ± 6.9) years old] ,menopausal duration was longer (11.6 ±2.9) years, bleeding duration was longer[ ( 157.6 ±26.4) days], and mucous membrane was obviously thickened[ (14.6 ±3.2) mini ( P 〈 0. 05) ,while there were no significant differences in gravidity and parity(P 〉 0.05). Conclusion The main cause for PMB is benign diseases, followed by non-organic diseases. More attentions should be paid to the PMB patients with higher attack age, longer menopausal duration and bleeding duration,and obviously thickened mucous membrane,so as to be precautious to the occurrence of malignant tumor.
出处 《中国基层医药》 CAS 2007年第9期1486-1488,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 阴道出血 恶性肿瘤 绝经后 Vaginal bleeding Malignant tumor Postmenopausal
  • 相关文献

参考文献5

二级参考文献40

  • 1夏恩兰,张玫,段惠兰,冯力民.子宫内膜切除术治疗月经过多400例分析[J].中华妇产科杂志,1997,32(3):148-151. 被引量:83
  • 2于洁.经阴道超声和宫腔镜检查在绝经后出血病人的应用[J].国外医学妇产科分册,1995,22(1):48-48.
  • 3汤春生 苏应宽 等.女性生殖器官解剖与生理.新编实用妇科学[M].济南:山东科技出版社,1995,11..
  • 4钟刚(译).绝经后子宫内膜的阴道超声检查[J].国外医学:妇产科学分册,1995,22(5):311-311.
  • 5Rosano GMC,Fini M.Hormone replacement therapy in postmenopausal women at cardiovascular risk:epidemiology and clinical trials.Gynaecol Forum,2001,6(1):24-27
  • 6Halley S,Grady D,Bush T,et al.Randomized trail of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women.JAMA,1998,280:605-613
  • 7LeBlanc ES,Janowsky J,Chan BK,et al.Hormone replacement therapy and cognition:systematic review and rectaanalysis.JAMA,2001,285(11):1489-1499
  • 8Birge SJ.Cognition,Alzheimer's disease and estrogen.Gynaecol Forum,2001,6(1):10-13
  • 9Schairer C,Lubin J,Troisi R,et al.Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.JAMA,2000,283(4):485-491
  • 10Delgado RC,Lubian Lopez DM.Prognosis of breast cancers detected in women receiving hormone replacement therapy.Maturitas,2001,38(2):147-156

共引文献27

同被引文献14

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部